Company profile for International Isotopes

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

International Isotopes Inc. (OTCQB: INIS) (the “Company”) is pleased to announce it has received approval from the U.S. Food and Drug Administration (FDA) for its SODIUM IODIDE I-131 pharmaceutical product. SODIUM IODIDE I-131 is a radioactive therapeutic agent indicated for the treatment of hyperthyroidism and selected cases of carcinoma of the thyroid.We bring the benefits of nuclear technology to a wide variety of medic...
International Isotopes Inc. (OTCQB: INIS) (the “Company”) is pleased to announce it has received approval from the U.S. Food and Drug Administration (FDA) for its SODIUM IODIDE I-131 pharmaceutical product. SODIUM IODIDE I-131 is a radioactive therapeutic agent indicated for the treatment of hyperthyroidism and selected cases of carcinoma of the thyroid.We bring the benefits of nuclear technology to a wide variety of medical and industrial applications. Our cobalt products are used by a broad array of companies for radiation treatment of cancer and vascular deformities of the brain.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4137 Commerce Circle Idaho Falls, ID 83401
Telephone
Telephone
(208) 524-5300
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/international-isotopes-inc-announces-fiscal-results-for-the-second-quarter-and-six-months-ended-june-30-2025-302528549.html

PR NEWSWIRE
13 Aug 2025

https://www.prnewswire.com/news-releases/international-isotopes-inc-expands-operational-footprint-with-strategic-land-acquisition-and-additional-new-facility-lease-agreement-302349527.html

PR NEWSWIRE
13 Jan 2025

https://www.prnewswire.com/news-releases/international-isotopes-inc-announces-fiscal-results-for-the-third-quarter-and-first-nine-months-of-2024-302303647.html

PR NEWSWIRE
13 Nov 2024

https://www.prnewswire.com/news-releases/inis-and-alpha-nuclides-sign-strategic-development-and-distribution-agreements-for-china-302167231.html

PR NEWSWIRE
07 Jun 2024

https://www.prnewswire.com/news-releases/international-isotopes-inc-announces-fiscal-results-for-the-third-quarter-and-first-nine-months-of-2023-301987046.html

PR NEWSWIRE
14 Nov 2023

https://www.prnewswire.com/news-releases/international-isotopes-inc-announces-fiscal-results-for-the-second-quarter-and-first-six-months-of-2023-301899297.html

PR NEWSWIRE
14 Aug 2023

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty